Literature DB >> 12614084

Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.

Marilena Vlachou1, George Papaïoannou.   

Abstract

A highly hydrophobic drug, furosemide, was treated with 2-Hydroxypropyl-beta-Cyclodextrin in an attempt to produce modified compounds with increased water solubility. Following a freeze-drying process, the interactions of furosemide and cyclodextrin led to the formation of an inclusion complex, whose dissolution rate in water was studied by the solubility method. Furthermore, mechanical mixtures of furosemide and cyclodextrin were also prepared and tested for their solubility. The reaction products were characterized in the solid state by differential scanning calorimetry (DSC), which provided some evidence about complexation. Additional evidence was obtained by recording the 1H NMR spectra of aqueous solutions of these same products. The study of phase solubility was based on the Higuchi & Connors method and showed an impressive enhancement of the miscibility of furosemide with water. In fact, a 11 fold increase of the drug solubility was recorded for the inclusion complex, in the first stages of dissolution. The experimental results of this work show that 2-Hydroxypropyl-beta-Cyclodextrin is an efficient complexation agent for furosemide. Combination of those two substances can be carried out by simple techniques, providing easy control and the obtained inclusion complex is characterized by acceptable water solubility and increased dissolution rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614084     DOI: 10.1177/0885328203017003557

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  2 in total

1.  Comparative evaluation of humic substances in oral drug delivery.

Authors:  Mohd Aamir Mirza; Niyaz Ahmad; Suraj Prakash Agarwal; Danish Mahmood; M Khalid Anwer; Z Iqbal
Journal:  Results Pharma Sci       Date:  2011-07-12

2.  Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation Enhancing Excipients for BCS Class IV Drugs.

Authors:  Mulazim Hussain Asim; Imran Nazir; Aamir Jalil; Flavia Laffleur; Barbara Matuszczak; Andreas Bernkop-Schnürch
Journal:  ACS Appl Mater Interfaces       Date:  2020-02-06       Impact factor: 9.229

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.